Duloxetine vs. Active Comparator in the Treatment of Patients With Depression

• Status: Completed
• Trial end date: 2004-05-01
• Target enrollment: 0
• Participant gender: All

Summary

How duloxetine compares to a medication currently available for the treatment of patients diagnosed with depression

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Duloxetine Hydrochloride; Venlafaxine Hydrochloride

Criteria

Inclusion Criteria:

• Must be at least 18 years of age

• Must be diagnosed with depression

• Must sign informed consent

• Women who can become pregnant must be using birth control

Exclusion Criteria:

• Previous diagnosis of bipolar disorder, schizophrenia, or other psychotic disorder

• History of substance abuse or dependence in the last year

• Patients who are suicidal

• Frequent or severe allergic reactions with multiple medications